- call +1-201-465-4211
- email sales@mrinsights.biz
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet veterinary drugs is increasing.
According to this study, over the next five years the Pet Veterinary Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pet Veterinary Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Pet Veterinary Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Hospitals
Veterinary Clinics
Drug Stores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pet Veterinary Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pet Veterinary Drug market by identifying its various subsegments.
Focuses on the key global Pet Veterinary Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pet Veterinary Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pet Veterinary Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Pet Veterinary Drug Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Veterinary Drug Consumption 2014-2024
2.1.2 Pet Veterinary Drug Consumption CAGR by Region
2.2 Pet Veterinary Drug Segment by Type
2.2.1 Anti-Infectives
2.2.2 Anti-Inflammatory
2.2.3 Parasiticides
2.2.4 Analgesics
2.2.5 Sedatives
2.2.6 Others
2.3 Pet Veterinary Drug Consumption by Type
2.3.1 Global Pet Veterinary Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Pet Veterinary Drug Sale Price by Type (2014-2019)
2.4 Pet Veterinary Drug Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Drug Stores
2.5 Pet Veterinary Drug Consumption by Application
2.5.1 Global Pet Veterinary Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Pet Veterinary Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Pet Veterinary Drug Sale Price by Application (2014-2019)
3 Global Pet Veterinary Drug by Manufacturers
3.1 Global Pet Veterinary Drug Sales Market Share by Manufacturers
3.1.1 Global Pet Veterinary Drug Sales by Manufacturers (2017-2019)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2017-2019)
3.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers
3.2.1 Global Pet Veterinary Drug Revenue by Manufacturers (2017-2019)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Pet Veterinary Drug Sale Price by Manufacturers
3.4 Global Pet Veterinary Drug Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Pet Veterinary Drug Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Pet Veterinary Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pet Veterinary Drug by Regions
4.1 Pet Veterinary Drug by Regions
4.1.1 Global Pet Veterinary Drug Consumption by Regions
4.1.2 Global Pet Veterinary Drug Value by Regions
4.2 Americas Pet Veterinary Drug Consumption Growth
4.3 APAC Pet Veterinary Drug Consumption Growth
4.4 Europe Pet Veterinary Drug Consumption Growth
4.5 Middle East & Africa Pet Veterinary Drug Consumption Growth
5 Americas
5.1 Americas Pet Veterinary Drug Consumption by Countries
5.1.1 Americas Pet Veterinary Drug Consumption by Countries (2014-2019)
5.1.2 Americas Pet Veterinary Drug Value by Countries (2014-2019)
5.2 Americas Pet Veterinary Drug Consumption by Type
5.3 Americas Pet Veterinary Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pet Veterinary Drug Consumption by Countries
6.1.1 APAC Pet Veterinary Drug Consumption by Countries (2014-2019)
6.1.2 APAC Pet Veterinary Drug Value by Countries (2014-2019)
6.2 APAC Pet Veterinary Drug Consumption by Type
6.3 APAC Pet Veterinary Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Pet Veterinary Drug by Countries
7.1.1 Europe Pet Veterinary Drug Consumption by Countries (2014-2019)
7.1.2 Europe Pet Veterinary Drug Value by Countries (2014-2019)
7.2 Europe Pet Veterinary Drug Consumption by Type
7.3 Europe Pet Veterinary Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pet Veterinary Drug by Countries
8.1.1 Middle East & Africa Pet Veterinary Drug Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Pet Veterinary Drug Value by Countries (2014-2019)
8.2 Middle East & Africa Pet Veterinary Drug Consumption by Type
8.3 Middle East & Africa Pet Veterinary Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pet Veterinary Drug Distributors
10.3 Pet Veterinary Drug Customer
11 Global Pet Veterinary Drug Market Forecast
11.1 Global Pet Veterinary Drug Consumption Forecast (2019-2024)
11.2 Global Pet Veterinary Drug Forecast by Regions
11.2.1 Global Pet Veterinary Drug Forecast by Regions (2019-2024)
11.2.2 Global Pet Veterinary Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pet Veterinary Drug Forecast by Type
11.8 Global Pet Veterinary Drug Forecast by Application
12 Key Players Analysis
12.1 Boehringer Ingelheim International GmbH
12.1.1 Company Details
12.1.2 Pet Veterinary Drug Product Offered
12.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim International GmbH News
12.2 Zoetis Animal Healthcare
12.2.1 Company Details
12.2.2 Pet Veterinary Drug Product Offered
12.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Zoetis Animal Healthcare News
12.3 Bayer AG
12.3.1 Company Details
12.3.2 Pet Veterinary Drug Product Offered
12.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Bayer AG News
12.4 Merck Animal Health
12.4.1 Company Details
12.4.2 Pet Veterinary Drug Product Offered
12.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Merck Animal Health News
12.5 Elanco Animal Health Inc.
12.5.1 Company Details
12.5.2 Pet Veterinary Drug Product Offered
12.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Elanco Animal Health Inc. News
12.6 Virbac Group
12.6.1 Company Details
12.6.2 Pet Veterinary Drug Product Offered
12.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Virbac Group News
12.7 Ceva
12.7.1 Company Details
12.7.2 Pet Veterinary Drug Product Offered
12.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Ceva News
12.8 Dechra Pharmaceuticals Plc
12.8.1 Company Details
12.8.2 Pet Veterinary Drug Product Offered
12.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Dechra Pharmaceuticals Plc News
12.9 Vetoquinol
12.9.1 Company Details
12.9.2 Pet Veterinary Drug Product Offered
12.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Vetoquinol News
12.10 Orion Corporation
12.10.1 Company Details
12.10.2 Pet Veterinary Drug Product Offered
12.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Orion Corporation News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Pet Veterinary Drug
Table Product Specifications of Pet Veterinary Drug
Figure Pet Veterinary Drug Report Years Considered
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
